 Premal Trivedi
Concepts (162)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Portasystemic Shunt, Transjugular Intrahepatic | 5 | 2021 | 36 | 3.350 |
Why?
| | Esophageal and Gastric Varices | 4 | 2021 | 31 | 2.750 |
Why?
| | Vena Cava Filters | 7 | 2023 | 50 | 2.230 |
Why?
| | Ischemic Attack, Transient | 3 | 2022 | 62 | 2.150 |
Why?
| | Radiology, Interventional | 3 | 2022 | 26 | 1.820 |
Why?
| | Radiology | 3 | 2023 | 141 | 1.580 |
Why?
| | Medicare | 7 | 2022 | 665 | 1.430 |
Why?
| | Practice Patterns, Physicians' | 6 | 2021 | 1177 | 1.340 |
Why?
| | Cholestasis | 2 | 2023 | 225 | 1.270 |
Why?
| | Gastrointestinal Hemorrhage | 3 | 2021 | 102 | 1.070 |
Why?
| | Pulmonary Embolism | 4 | 2021 | 181 | 1.020 |
Why?
| | Renal Dialysis | 2 | 2020 | 374 | 1.010 |
Why?
| | Peripheral Arterial Disease | 2 | 2022 | 380 | 0.980 |
Why?
| | United States | 21 | 2022 | 12183 | 0.880 |
Why?
| | Hyperaldosteronism | 1 | 2023 | 8 | 0.870 |
Why?
| | Stroke | 2 | 2022 | 1022 | 0.870 |
Why?
| | Endoscopy, Gastrointestinal | 3 | 2022 | 203 | 0.860 |
Why?
| | Angioplasty, Balloon | 1 | 2022 | 88 | 0.750 |
Why?
| | Biliary Tract Surgical Procedures | 1 | 2021 | 21 | 0.730 |
Why?
| | Chemoembolization, Therapeutic | 1 | 2021 | 45 | 0.730 |
Why?
| | End Stage Liver Disease | 1 | 2021 | 63 | 0.690 |
Why?
| | Hepatorenal Syndrome | 1 | 2019 | 14 | 0.670 |
Why?
| | Treatment Outcome | 12 | 2023 | 9088 | 0.670 |
Why?
| | Carcinoma, Hepatocellular | 1 | 2021 | 211 | 0.650 |
Why?
| | Specialization | 1 | 2020 | 115 | 0.640 |
Why?
| | Medicine | 1 | 2020 | 102 | 0.630 |
Why?
| | Neuroimaging | 1 | 2020 | 249 | 0.600 |
Why?
| | Arteriovenous Shunt, Surgical | 1 | 2018 | 15 | 0.590 |
Why?
| | Graft Occlusion, Vascular | 1 | 2018 | 35 | 0.580 |
Why?
| | Retrospective Studies | 12 | 2023 | 12550 | 0.570 |
Why?
| | Healthcare Disparities | 1 | 2022 | 480 | 0.560 |
Why?
| | Leptin | 2 | 2008 | 210 | 0.550 |
Why?
| | Liver Neoplasms | 1 | 2021 | 506 | 0.550 |
Why?
| | Lower Extremity | 1 | 2020 | 335 | 0.540 |
Why?
| | Emergency Service, Hospital | 3 | 2022 | 1815 | 0.520 |
Why?
| | Endovascular Procedures | 1 | 2020 | 269 | 0.520 |
Why?
| | Ascites | 1 | 2016 | 32 | 0.520 |
Why?
| | Liver Transplantation | 1 | 2023 | 707 | 0.510 |
Why?
| | Hypertension, Portal | 1 | 2016 | 61 | 0.500 |
Why?
| | Logistic Models | 5 | 2021 | 1841 | 0.500 |
Why?
| | Humans | 32 | 2023 | 114686 | 0.490 |
Why?
| | Databases, Factual | 6 | 2022 | 1125 | 0.440 |
Why?
| | Practice Guidelines as Topic | 1 | 2020 | 1395 | 0.410 |
Why?
| | Radiography | 3 | 2023 | 812 | 0.390 |
Why?
| | Patient Discharge | 3 | 2022 | 772 | 0.370 |
Why?
| | Constriction, Pathologic | 2 | 2023 | 208 | 0.370 |
Why?
| | Catheterization | 2 | 2023 | 159 | 0.370 |
Why?
| | Device Removal | 2 | 2023 | 126 | 0.370 |
Why?
| | Aged | 11 | 2022 | 19074 | 0.360 |
Why?
| | Aged, 80 and over | 7 | 2021 | 6347 | 0.360 |
Why?
| | Neoplasms | 1 | 2023 | 2097 | 0.330 |
Why?
| | Apoptosis | 2 | 2008 | 2363 | 0.330 |
Why?
| | Cross-Sectional Studies | 4 | 2022 | 4409 | 0.310 |
Why?
| | Middle Aged | 10 | 2023 | 26737 | 0.300 |
Why?
| | Muscle Cells | 1 | 2007 | 42 | 0.290 |
Why?
| | Male | 14 | 2023 | 55596 | 0.290 |
Why?
| | Cardiomegaly | 1 | 2007 | 157 | 0.270 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2007 | 329 | 0.260 |
Why?
| | Hospitals | 2 | 2021 | 581 | 0.250 |
Why?
| | Cohort Studies | 4 | 2023 | 4895 | 0.240 |
Why?
| | Myocytes, Cardiac | 1 | 2008 | 449 | 0.240 |
Why?
| | Female | 12 | 2023 | 59507 | 0.230 |
Why?
| | Severity of Illness Index | 2 | 2021 | 2539 | 0.220 |
Why?
| | Adult | 8 | 2021 | 30550 | 0.220 |
Why?
| | Aldosterone | 1 | 2023 | 42 | 0.220 |
Why?
| | Hospitalization | 3 | 2021 | 1752 | 0.210 |
Why?
| | Adrenal Glands | 1 | 2023 | 66 | 0.210 |
Why?
| | Watchful Waiting | 1 | 2023 | 55 | 0.210 |
Why?
| | Gallbladder Diseases | 1 | 2022 | 6 | 0.200 |
Why?
| | Atherectomy | 1 | 2022 | 33 | 0.200 |
Why?
| | Cholecystostomy | 1 | 2021 | 4 | 0.190 |
Why?
| | Cholecystitis, Acute | 1 | 2021 | 16 | 0.190 |
Why?
| | Cholecystectomy | 1 | 2021 | 45 | 0.180 |
Why?
| | Femoral Artery | 1 | 2022 | 167 | 0.180 |
Why?
| | Vena Cava, Inferior | 1 | 2021 | 56 | 0.180 |
Why?
| | Oropharynx | 1 | 2020 | 36 | 0.180 |
Why?
| | Mouth | 1 | 2020 | 70 | 0.180 |
Why?
| | Larynx | 1 | 2020 | 47 | 0.170 |
Why?
| | Administrative Claims, Healthcare | 1 | 2020 | 22 | 0.170 |
Why?
| | Radiologists | 1 | 2020 | 35 | 0.170 |
Why?
| | Cardiologists | 1 | 2020 | 40 | 0.170 |
Why?
| | Costs and Cost Analysis | 1 | 2020 | 196 | 0.170 |
Why?
| | Ambulatory Surgical Procedures | 1 | 2020 | 48 | 0.170 |
Why?
| | Time Factors | 3 | 2020 | 6115 | 0.170 |
Why?
| | Hemorrhage | 1 | 2023 | 620 | 0.160 |
Why?
| | Inpatients | 2 | 2019 | 380 | 0.160 |
Why?
| | Recurrence | 1 | 2021 | 935 | 0.160 |
Why?
| | Odds Ratio | 1 | 2021 | 953 | 0.160 |
Why?
| | Acute Disease | 1 | 2021 | 911 | 0.150 |
Why?
| | Socioeconomic Factors | 1 | 2022 | 1078 | 0.150 |
Why?
| | Adolescent | 6 | 2021 | 17844 | 0.150 |
Why?
| | Cost-Benefit Analysis | 1 | 2021 | 544 | 0.150 |
Why?
| | Venous Thromboembolism | 2 | 2018 | 231 | 0.150 |
Why?
| | Liver Cirrhosis | 1 | 2019 | 227 | 0.150 |
Why?
| | Vascular Patency | 1 | 2018 | 97 | 0.150 |
Why?
| | Cardiovascular Diseases | 1 | 2008 | 1727 | 0.140 |
Why?
| | Radiology Department, Hospital | 1 | 2017 | 15 | 0.140 |
Why?
| | Prosthesis Implantation | 1 | 2018 | 138 | 0.140 |
Why?
| | Linear Models | 2 | 2017 | 768 | 0.140 |
Why?
| | Product Surveillance, Postmarketing | 1 | 2017 | 63 | 0.140 |
Why?
| | Drug Utilization | 1 | 2017 | 167 | 0.130 |
Why?
| | Obesity | 1 | 2008 | 2508 | 0.130 |
Why?
| | Personnel Selection | 1 | 2017 | 62 | 0.130 |
Why?
| | Ambulatory Care | 1 | 2020 | 478 | 0.130 |
Why?
| | Inservice Training | 1 | 2017 | 105 | 0.130 |
Why?
| | Surgeons | 1 | 2020 | 239 | 0.130 |
Why?
| | Hospital Mortality | 2 | 2018 | 776 | 0.130 |
Why?
| | Prevalence | 1 | 2021 | 2251 | 0.120 |
Why?
| | Comorbidity | 2 | 2018 | 1448 | 0.120 |
Why?
| | Faculty, Medical | 1 | 2017 | 228 | 0.120 |
Why?
| | Carcinoma, Non-Small-Cell Lung | 1 | 2022 | 961 | 0.110 |
Why?
| | Longitudinal Studies | 1 | 2020 | 2387 | 0.110 |
Why?
| | Young Adult | 4 | 2021 | 10469 | 0.110 |
Why?
| | Anticoagulants | 1 | 2017 | 550 | 0.110 |
Why?
| | Internship and Residency | 1 | 2022 | 926 | 0.100 |
Why?
| | Sex Factors | 1 | 2018 | 1715 | 0.100 |
Why?
| | Multivariate Analysis | 1 | 2016 | 1430 | 0.100 |
Why?
| | Risk Factors | 3 | 2017 | 8632 | 0.100 |
Why?
| | Follow-Up Studies | 1 | 2020 | 4411 | 0.100 |
Why?
| | Length of Stay | 1 | 2016 | 962 | 0.090 |
Why?
| | Heart Failure | 2 | 2018 | 1945 | 0.090 |
Why?
| | Fluorodeoxyglucose F18 | 2 | 2022 | 113 | 0.090 |
Why?
| | Survival Rate | 2 | 2018 | 1644 | 0.090 |
Why?
| | Positron-Emission Tomography | 2 | 2022 | 259 | 0.090 |
Why?
| | Lung Neoplasms | 1 | 2022 | 2177 | 0.080 |
Why?
| | Rats, Zucker | 1 | 2008 | 27 | 0.080 |
Why?
| | Mice, Obese | 1 | 2007 | 53 | 0.070 |
Why?
| | Class I Phosphatidylinositol 3-Kinases | 1 | 2007 | 76 | 0.070 |
Why?
| | Catalysis | 1 | 2007 | 289 | 0.070 |
Why?
| | Caspase 3 | 1 | 2007 | 235 | 0.070 |
Why?
| | Neoplasm Recurrence, Local | 2 | 2022 | 858 | 0.070 |
Why?
| | Sensitivity and Specificity | 1 | 2008 | 1692 | 0.060 |
Why?
| | Rats, Sprague-Dawley | 1 | 2008 | 2218 | 0.060 |
Why?
| | Myocardium | 1 | 2007 | 913 | 0.050 |
Why?
| | Interdisciplinary Research | 1 | 2022 | 25 | 0.050 |
Why?
| | Positron Emission Tomography Computed Tomography | 1 | 2022 | 63 | 0.050 |
Why?
| | Radiopharmaceuticals | 1 | 2022 | 157 | 0.050 |
Why?
| | Gallbladder | 1 | 2021 | 15 | 0.050 |
Why?
| | Insulin Resistance | 1 | 2008 | 1072 | 0.040 |
Why?
| | Laryngeal Neoplasms | 1 | 2020 | 27 | 0.040 |
Why?
| | Rats | 1 | 2008 | 4958 | 0.040 |
Why?
| | Consensus | 1 | 2022 | 537 | 0.040 |
Why?
| | Disease Models, Animal | 1 | 2008 | 3535 | 0.040 |
Why?
| | Disease-Free Survival | 1 | 2020 | 620 | 0.040 |
Why?
| | Hospital Bed Capacity | 1 | 2018 | 21 | 0.040 |
Why?
| | Hospitals, Teaching | 1 | 2018 | 103 | 0.040 |
Why?
| | Hospitals, Urban | 1 | 2018 | 127 | 0.040 |
Why?
| | Animals | 2 | 2008 | 31706 | 0.030 |
Why?
| | United States Food and Drug Administration | 1 | 2017 | 172 | 0.030 |
Why?
| | Signal Transduction | 1 | 2008 | 4513 | 0.030 |
Why?
| | Clinical Decision-Making | 1 | 2018 | 268 | 0.030 |
Why?
| | Career Choice | 1 | 2017 | 177 | 0.030 |
Why?
| | Combined Modality Therapy | 1 | 2017 | 1121 | 0.030 |
Why?
| | Hospitals, Pediatric | 1 | 2017 | 480 | 0.030 |
Why?
| | Mice | 1 | 2007 | 14869 | 0.020 |
Why?
| | Quality of Life | 1 | 2022 | 2353 | 0.020 |
Why?
| | Age Factors | 1 | 2018 | 2894 | 0.020 |
Why?
| | Curriculum | 1 | 2017 | 819 | 0.020 |
Why?
| | Prospective Studies | 1 | 2022 | 6220 | 0.020 |
Why?
| | Surveys and Questionnaires | 1 | 2022 | 4623 | 0.020 |
Why?
| | Child, Preschool | 1 | 2017 | 9116 | 0.010 |
Why?
| | Child | 1 | 2017 | 18414 | 0.010 |
Why?
|
|
Trivedi's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|